n,n'-bis(2-hydroxybenzyl)ethylenediamine-n,n'-diacetic acid has been researched along with Transfusion Reaction in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (33.33) | 18.7374 |
1990's | 2 (66.67) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Grady, RW; Hershko, C; Link, G | 1 |
Giardina, PJ; Grady, RW; Hilgartner, MW; Salbe, AD | 1 |
Bergeron, RJ; Brittenham, GM; Wiegand, J | 1 |
1 trial(s) available for n,n'-bis(2-hydroxybenzyl)ethylenediamine-n,n'-diacetic acid and Transfusion Reaction
Article | Year |
---|---|
Results from a phase I clinical trial of HBED.
Topics: Adolescent; Adult; beta-Thalassemia; Chelating Agents; Deferoxamine; Edetic Acid; Female; Humans; Iron; Male; Transfusion Reaction | 1994 |
2 other study(ies) available for n,n'-bis(2-hydroxybenzyl)ethylenediamine-n,n'-diacetic acid and Transfusion Reaction
Article | Year |
---|---|
Development and evaluation of the improved iron chelating agents EHPG, HBED and their dimethyl esters.
Topics: Administration, Oral; Animals; Deferoxamine; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Drug Interactions; Edetic Acid; Ethylenediamines; Female; Infusions, Parenteral; Iron Chelating Agents; Iron Radioisotopes; Rats; Rats, Inbred Strains; Transfusion Reaction | 1984 |
HBED: A potential alternative to deferoxamine for iron-chelating therapy.
Topics: Animals; Antidotes; Chelating Agents; Deferoxamine; Edetic Acid; Haplorhini; Iron Overload; Male; Rats; Rats, Sprague-Dawley; Transfusion Reaction | 1998 |